Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information


Bedford, USA
36 Crosby Drive,
Suite 101,
Bedford, MA, 01730


President and CEO
Board Member
Co - Founder, Director & Chairman


TOTAL $73.3M
Series C, 6/2009
Polaris Partners
Versant Ventures
SV Life Sciences
Venture Round, 7/2009
Series C, 1/2011
Series D, 2/2011
Series D, 1/2013
Polaris Partners
Versant Ventures
SV Life Sciences
Ascension Ventures
Series E, 6/2013
Ascension Ventures
Baxter International


Ocular Therapeutix

Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.

Recent Milestones



Ocular Therapeutix screenshot
Above: Home
Uploaded: 6/24/09


  1. I-Therapeutix, Inc.: Series C $15M ( [edit]
  2. SEC ( [edit]
  3. Ocular Therapeutix Adds $6M to C Round ( [edit]
  4. Ocular Therapeutix Raises $14M Series D ( [edit]
  5. Ocular Therapeutix, Inc. Closes on $23.8 Million Series D Extension ( [edit]
  6. Ocular Therapeutix gets $8.5M, Baxter secures minority stake ( [edit]
  7. Ocular Therapeutix pushes last round to $21M ( [edit]
Edit This Page
Last Edited 3/28/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy